Your Article Summary
See Latest ArticlesModern preoperative and intraoperative management of hereditary angioedema
Allergy and Asthma Proceedings, 06/24/09
Szema AM et al. - Biotechnology in the form of novel but currently available and in-practice medical devices, as well as new therapeutic agents, have expanded the armamentarium for safely managing patients with HAE pre- and intraoperatively.
Related Articles
Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09
Relevance Score: 87%
Anaphylaxis and angioedema
Dermatology in Practice, 10/09/09
Relevance Score: 87%
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09
Relevance Score: 87%
Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema
The Laryngoscope, 11/06/09
Relevance Score: 84%
Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09
Relevance Score: 84%
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema a combined psychophysical and neuroimaging study
Allergy, 12/18/09
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09